Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott N. Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott J. Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure-Kunkel, Shruti Agrawal, Daniel McDonald, Georgia D. Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol

Open source

DOI
10.1056/nejmoa1200690
Published
2012-06-28
Container
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1200690,
  title = {Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer},
  author = {Suzanne L. Topalian and F. Stephen Hodi and Julie R. Brahmer and Scott N. Gettinger and David C. Smith and David F. McDermott and John D. Powderly and Richard D. Carvajal and Jeffrey A. Sosman and Michael B. Atkins and Philip D. Leming and David R. Spigel and Scott J. Antonia and Leora Horn and Charles G. Drake and Drew M. Pardoll and Lieping Chen and William H. Sharfman and Robert A. Anders and Janis M. Taube and Tracee L. McMiller and Haiying Xu and Alan J. Korman and Maria Jure-Kunkel and Shruti Agrawal and Daniel McDonald and Georgia D. Kollia and Ashok Gupta and Jon M. Wigginton and Mario Sznol},
  year = {2012},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa1200690},
  url = {https://doi.org/10.1056/nejmoa1200690}
}

RIS

TY  - JOUR
TI  - Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
AU  - Suzanne L. Topalian
AU  - F. Stephen Hodi
AU  - Julie R. Brahmer
AU  - Scott N. Gettinger
AU  - David C. Smith
AU  - David F. McDermott
AU  - John D. Powderly
AU  - Richard D. Carvajal
AU  - Jeffrey A. Sosman
AU  - Michael B. Atkins
AU  - Philip D. Leming
AU  - David R. Spigel
AU  - Scott J. Antonia
AU  - Leora Horn
AU  - Charles G. Drake
AU  - Drew M. Pardoll
AU  - Lieping Chen
AU  - William H. Sharfman
AU  - Robert A. Anders
AU  - Janis M. Taube
AU  - Tracee L. McMiller
AU  - Haiying Xu
AU  - Alan J. Korman
AU  - Maria Jure-Kunkel
AU  - Shruti Agrawal
AU  - Daniel McDonald
AU  - Georgia D. Kollia
AU  - Ashok Gupta
AU  - Jon M. Wigginton
AU  - Mario Sznol
PY  - 2012
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa1200690
UR  - https://doi.org/10.1056/nejmoa1200690
ER  - 

APA

Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., Leming, P. D., Spigel, D. R., Antonia, S. J., Horn, L., Drake, C. G., Pardoll, D. M., Chen, L., Sharfman, W. H., Anders, R. A., Taube, J. M., McMiller, T. L., Xu, H., Korman, A. J., Jure-Kunkel, M., Agrawal, S., McDonald, D., Kollia, G. D., Gupta, A., Wigginton, J. M., & Sznol, M. (2012). Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1200690

Source records